SENS PubMed Publication Search
Dihydroquinazolines enhance 20S proteasome activity and induce degradation of α-synuclein, an intrinsically disordered protein associated with neurodegeneration
Bioorg Med Chem Lett. 2021 Mar 15;36:127821. doi: 10.1016/j.bmcl.2021.127821.
Taylor J Fiolek 1, Christina L Magyar 2, Tyler J Wall 2, Steven B Davies 2, Molly V Campbell 2, Christopher J Savich 2, Jetze J Tepe 3, R Adam Mosey 4
Abstract:
...Herein, we synthesized and evaluated a library of dihydroquinazoline analogues and discovered several promising new 20S proteasome activators. Further testing of top hits revealed that they can enhance 20S mediated degradation of α-synuclein, the IDP associated with Parkinson's disease.
PMID: 33513387
Free Full-Text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925381/